{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:50:15Z","timestamp":1793109015284,"version":"4.5.0"},"reference-count":44,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0080","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T13:25:00Z","timestamp":1716297900000},"source":"Crossref","is-referenced-by-count":8,"title":["Mistletoe extract in patients with advanced pancreatic cancer: a double-blind, randomized, placebo-controlled trial (MISTRAL)"],"prefix":"10.3238","author":[{"given":"Kathrin","family":"Wode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunver S.","family":"Kienle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ove","family":"Bj\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Fransson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils O.","family":"Elander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt-Marie","family":"Bernhardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Edwinsdotter","family":"Ardnor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Scheibling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna H\u00f6k","family":"Nordberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"10.3238\/arztebl.m2024.0080_ref1","doi-asserted-by":"crossref","unstructured":"Park W, Chawla A, O’Reilly EM: Pancreatic cancer: a review. J Jama 2021; 326: 851–62.","DOI":"10.1001\/jama.2021.13027"},{"key":"10.3238\/arztebl.m2024.0080_ref2","doi-asserted-by":"crossref","unstructured":"Carrato A, Falcone A, Ducreux M, et al.: A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs. J Gastrointest Cancer 2015; 46: 201–11.","DOI":"10.1007\/s12029-015-9724-1"},{"key":"10.3238\/arztebl.m2024.0080_ref3","doi-asserted-by":"crossref","unstructured":"Loef M, Walach H: Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis. BMC Complement Med Ther 2020; 20: 227.","DOI":"10.1186\/s12906-020-03013-3"},{"key":"10.3238\/arztebl.m2024.0080_ref4","doi-asserted-by":"crossref","unstructured":"Molassiotis A, Fernadez-Ortega P, Pud D, et al.: Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16: 655–63.","DOI":"10.1093\/annonc\/mdi110"},{"key":"10.3238\/arztebl.m2024.0080_ref5","doi-asserted-by":"crossref","unstructured":"Rostock M: Die Misteltherapie in der Behandlung von Patienten mit einer Krebserkrankung. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2020; 63: 535–40.","DOI":"10.1007\/s00103-020-03122-x"},{"key":"10.3238\/arztebl.m2024.0080_ref6","doi-asserted-by":"crossref","unstructured":"M\u00fcnstedt K, Harren H, von Georgi R, Hackethal A: Complementary and alternative medicine: comparison of current knowledge, attitudes and interest among German medical students and doctors. J Evid Based Complementary Altern Med 2011; 2011: 790951.","DOI":"10.1093\/ecam\/nen079"},{"key":"10.3238\/arztebl.m2024.0080_ref7","doi-asserted-by":"crossref","unstructured":"Steigenberger C, Schnell-Inderst P, Flatscher-Th\u00f6ni M, Plank LM, Siebert U: Patients’ and social aspects related to complementary mistletoe therapy in patients with breast cancer: a systematic review commissioned by the German agency for health technology assessment. Eur J Oncol Nurs 2023; 65: 102338.","DOI":"10.1016\/j.ejon.2023.102338"},{"key":"10.3238\/arztebl.m2024.0080_ref8","doi-asserted-by":"crossref","unstructured":"Z\u00e4nker KS, Kaveri SV: Mistletoe: from mythology to evidence-based medicine. Basel, Schweiz: S. Karger AG; 2015.","DOI":"10.1159\/978-3-318-05445-3"},{"key":"10.3238\/arztebl.m2024.0080_ref9","doi-asserted-by":"crossref","unstructured":"Beztsinna N, De Matos MBC, Walther J, et al.: Quantitative analysis of receptor-mediated uptake and pro-apoptotic activity of mistletoe lectin-1 by high content imaging. Sci Rep 2018; 8: 2768.","DOI":"10.1038\/s41598-018-20915-y"},{"key":"10.3238\/arztebl.m2024.0080_ref10","doi-asserted-by":"crossref","unstructured":"Werthmann PG, Hintze A, Kienle GS: Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract: a case report. Medicine (Baltimore) 2017; 96: e8731.","DOI":"10.1097\/MD.0000000000008731"},{"key":"10.3238\/arztebl.m2024.0080_ref11","doi-asserted-by":"crossref","unstructured":"Mabed M, El-Helw L, Shamaa S: Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma. Br J Cancer 2004; 90: 65–9.","DOI":"10.1038\/sj.bjc.6601463"},{"key":"10.3238\/arztebl.m2024.0080_ref12","doi-asserted-by":"crossref","unstructured":"Werthmann PG, Huber R, Kienle GS: Durable clinical remission of a skull metastasis under intralesional Viscum album extract therapy: case report. Head Neck 2018; 40: E77–E81.","DOI":"10.1002\/hed.25320"},{"key":"10.3238\/arztebl.m2024.0080_ref13","doi-asserted-by":"crossref","unstructured":"Ostermann T, Appelbaum S, Poier D, Boehm K, Raak C, B\u00fcssing A: A systematic review and meta-analysis on the survival of cancer patients treated with a fermented Viscum album L. Extract (Iscador): an update of findings. Complement Med Res 2020; 27: 260–71.","DOI":"10.1159\/000505202"},{"key":"10.3238\/arztebl.m2024.0080_ref14","doi-asserted-by":"crossref","unstructured":"Tr\u00f6ger W, Galun D, Reif M, Schumann A, Stanković N, Milićević M: Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer 2013; 49: 3788–97.","DOI":"10.1016\/j.ejca.2013.06.043"},{"key":"10.3238\/arztebl.m2024.0080_ref15","unstructured":"Tr\u00f6ger W, Galun D, Reif M, Schumann A, Stanković N, Milićević M: Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe—a randomized controlled trial. Dtsch Arztebl Int 2014; 111: 493–502."},{"key":"10.3238\/arztebl.m2024.0080_ref16","doi-asserted-by":"crossref","unstructured":"Gerhard I, Abel U, Loewe-Mesch A, Huppmann S, Kuehn J: [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer]. Forsch Komplementarmed Klass Naturheilkd 2004; 11: 150–7.","DOI":"10.1159\/000079444"},{"key":"10.3238\/arztebl.m2024.0080_ref17","doi-asserted-by":"crossref","unstructured":"Wode K, Hok Nordberg J, Kienle GS, et al.: Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL). Trials 2020; 21: 783.","DOI":"10.1186\/s13063-020-04581-y"},{"key":"10.3238\/arztebl.m2024.0080_ref18","doi-asserted-by":"crossref","unstructured":"Axelsson B: The challenge: equal availability to palliative care according to individual need regardless of age, diagnosis, geographical location, and care level. Int J Environ Res Public Health 2022; 19: 4229.","DOI":"10.3390\/ijerph19074229"},{"key":"10.3238\/arztebl.m2024.0080_ref19","unstructured":"Iscador Ltd: Iscador in Cancer Therapy. 2016; p. 20."},{"key":"10.3238\/arztebl.m2024.0080_ref20","doi-asserted-by":"crossref","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–76.","DOI":"10.1093\/jnci\/85.5.365"},{"key":"10.3238\/arztebl.m2024.0080_ref21","unstructured":"R Core Team: R: A language and environment for statistical computing. Version 4.2.2. R Foundation for Statistical Computing, Vienna, Austria 2021. www.R-project.org\/ (last accessed on 7 May 2024)."},{"key":"10.3238\/arztebl.m2024.0080_ref22","doi-asserted-by":"crossref","unstructured":"Kordes M, Yu J, Malgerud O, Gustafsson Liljefors M, Lohr J: Survival benefits of chemotherapy for patients with advanced pancreatic cancer in a clinical real-world cohort. Cancers 2019; 11: 1326.","DOI":"10.3390\/cancers11091326"},{"key":"10.3238\/arztebl.m2024.0080_ref23","doi-asserted-by":"crossref","unstructured":"Schaefermeyer G, Schaefermeyer H: Treatment of pancreatic cancer with Viscum album (Iscador): a retrospective study of 292 patients 1986–1996. Complementary Therapies in Medicine 1998; 6: 172–7.","DOI":"10.1016\/S0965-2299(98)80024-1"},{"key":"10.3238\/arztebl.m2024.0080_ref24","unstructured":"Delius-M\u00fcller U: Ergebnisse der Iscadortherapie bei der Behandlung des Pankreaskarzinoms in der Lukas-Klinik. Mitteil Behandl malig Tumoren 1979; 11: 5–8."},{"key":"10.3238\/arztebl.m2024.0080_ref25","unstructured":"Friess H, Beger HG, Kunz J, Funk N, Schilling M, Buchler MW: Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial. Anticancer Res 1996; 16: 915–20."},{"key":"10.3238\/arztebl.m2024.0080_ref26","doi-asserted-by":"crossref","unstructured":"Matthes H, Friedel WE, Bock PR, Zanker KS: Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. CurrMolMed 2010; 10: 430–9.","DOI":"10.2174\/156652410791317057"},{"key":"10.3238\/arztebl.m2024.0080_ref27","unstructured":"Reif M, Lemche A, Galun D, Tr\u00f6ger W: Pain and use of analgesics in a randomized study of metastasized or locally advanced pancreatic carcinoma (MAPAC) in: Scheer R, Alban S, Becker H, et al. (eds.): Die Mistel in der Tumortherapie 5 – Aktueller Stand der Forschung und klinische Anwendung. Essen: KVC Verlag 2020; p. 257–68."},{"key":"10.3238\/arztebl.m2024.0080_ref28","doi-asserted-by":"crossref","unstructured":"Bockorny B, Grossman JE, Hidalgo M: Facts and hopes in immunotherapy of pancreatic cancer. Clin Cancer Res 2022; 28: 4606–17.","DOI":"10.1158\/1078-0432.CCR-21-3452"},{"key":"10.3238\/arztebl.m2024.0080_ref29","doi-asserted-by":"crossref","unstructured":"Connor SR: Global Atlas of Palliative Care. 2nd ed. London, UK: Worldwide Hospice Palliative Care Alliance (WHPCA); 2020.","DOI":"10.1007\/978-3-319-77740-5_4"},{"key":"10.3238\/arztebl.m2024.0080_ref30","doi-asserted-by":"crossref","unstructured":"Smith TJ, Temin S, Alesi ER, et al.: American society of clinical oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012; 30: 880–7.","DOI":"10.1200\/JCO.2011.38.5161"},{"key":"10.3238\/arztebl.m2024.0080_ref31","doi-asserted-by":"crossref","unstructured":"Loewe-Mesch A, Kuehn JJ, Borho K, et al.: [Adjuvant simultaneous mistletoe chemotherapy in breast cancer—influence on immunological parameters, quality of life and tolerability]. Forsch Komplementmed 2008; 15: 22–30.","DOI":"10.1159\/000112860"},{"key":"10.3238\/arztebl.m2024.0080_ref32","doi-asserted-by":"crossref","unstructured":"Steele ML, Axtner J, Happe A, Kr\u00f6z M, Matthes H, Schad F: Adverse drug reactions and expected effects to therapy with subcutaneous mistletoe extracts (Viscum album L.) in cancer patients. Evid Based Complement Alternat Med 2014: 2014: 724258.","DOI":"10.1155\/2014\/724258"},{"key":"10.3238\/arztebl.m2024.0080_ref33","doi-asserted-by":"crossref","unstructured":"Chan WJJ, Adiwidjaja J, McLachlan AJ, Boddy AV, Harnett JE: Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance. Cancer Chemother Pharmacol 2023; 91: 103–19.","DOI":"10.1007\/s00280-023-04504-z"},{"key":"10.3238\/arztebl.m2024.0080_ref34","doi-asserted-by":"crossref","unstructured":"Mansky PJ, Wallerstedt DB, Sannes TS, et al.: NCCAM\/NCI phase 1 study of mistletoe extract and gemcitabine in patients with advanced solid tumors. Evid Based Complement Alternat Med 2013: 2013: 964592.","DOI":"10.1155\/2013\/964592"},{"key":"10.3238\/arztebl.m2024.0080_ref35","doi-asserted-by":"crossref","unstructured":"Fischer F, Lewith G, Witt CM, et al.: A research roadmap for complementary and alternative medicine—what we need to know by 2020. Forsch Komplementmed 2014; 21: 1–16.","DOI":"10.1159\/000360744"},{"key":"10.3238\/arztebl.m2024.0080_ref36","doi-asserted-by":"crossref","unstructured":"Hohneck AL, Sadikaj L, Heinemann L, et al.: Patients with advanced pancreatic cancer treated with mistletoe and hyperthermia in addition to palliative chemotherapy: a retrospective single-center analysis. Cancers 2023; 15: 4929.","DOI":"10.3390\/cancers15204929"},{"key":"10.3238\/arztebl.m2024.0080_ref37","doi-asserted-by":"crossref","unstructured":"Axtner J, Steele M, Kr\u00f6z M, Spahn G, Matthes H, Schad F: Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer. BMC Cancer 2016; 16: 579.","DOI":"10.1186\/s12885-016-2594-5"},{"key":"10.3238\/arztebl.m2024.0080_ref38","doi-asserted-by":"crossref","unstructured":"Werthmann PG, Inter P, Welsch T, et al.: Long-term tumor-free survival in a metastatic pancreatic carcinoma patient with FOLFIRINOX\/Mitomycin, high-dose, fever inducing Viscum album extracts and subsequent R0 resection: a case report. Medicine (Baltimore) 2018; 97: e13243.","DOI":"10.1097\/MD.0000000000013243"},{"key":"10.3238\/arztebl.m2024.0080_ref39","doi-asserted-by":"crossref","unstructured":"Ritter PR, Tischoff I, Uhl W, Schmidt WE, Meier JJ: Sustained partial remission of metastatic pancreatic cancer following systemic chemotherapy with gemcitabine and oxaliplatin plus adjunctive treatment with mistletoe extract. Onkologie 2010; 33: 617–9.","DOI":"10.1159\/000321133"},{"key":"10.3238\/arztebl.m2024.0080_ref40","unstructured":"Matthes H, Schad F, Schenk G: Endoscopic ultrasound-guided fine-needle injection of Viscum Album L. (mistletoe; Helixor \u00a9 M) in the therapy of primary inoperable pancreas cancer: a pilot study. Gastroenterology 2005; 128: 433–4."},{"key":"10.3238\/arztebl.m2024.0080_ref41","doi-asserted-by":"crossref","unstructured":"Conroy T, Desseigne Fo, Ychou M, et al.: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817–25.","DOI":"10.1056\/NEJMoa1011923"},{"key":"10.3238\/arztebl.m2024.0080_ref42","doi-asserted-by":"crossref","unstructured":"Von Hoff DD, Ervin T, Arena FP, et al.: Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691–703.","DOI":"10.1056\/NEJMoa1304369"},{"key":"10.3238\/arztebl.m2024.0080_ref43","unstructured":"Kienle GS, Kiene H: Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res 2007; 12: 103–19."},{"key":"10.3238\/arztebl.m2024.0080_ref44","unstructured":"Huber R, Rostock M, Goedl R, Ludtke R, Urech K, Klein R: Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects. J Soc Integr Oncol 2006; 4: 3–7."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T13:25:30Z","timestamp":1716297930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":44,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0080","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}